| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Biomedical NMR, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands;
Department of Human Movement Sciences and
Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands; and
Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands
1Correspondence and current address: Yale University, MRRC, TAC N 136, 300 Cedar St., PO Box 208043, New Haven, CT 06520-8043, USA. E-mail: henk.defeyter{at}yale.edu
Currently inherited or acquired skeletal muscle mitochondrial dysfunction is linked to dysregulated fatty acid metabolism, resulting in increased levels of intramyocellular lipids (IMCLs) and lipid intermediates, inducing insulin resistance. The present study aimed to clarify the order of changes in IMCL levels and skeletal muscle mitochondrial function during the development of type 2 diabetes in Zucker diabetic fatty (ZDF) rats. IMCL levels and skeletal muscle oxidative capacity were determined in vivo, using localized 1H magnetic resonance spectroscopy (MRS) and dynamic 31P MRS, respectively. In parallel, in vitro activities were measured from enzymes involved in fatty acid oxidation, the tricarboxylic acid cycle and the electron transport chain. Fa/fa ZDF rats were studied at 3 different ages corresponding to different stages of type 2 diabetes, whereas fa/+ rats served as controls. Fa/fa ZDF rats had higher IMCL contents than controls throughout the duration of the study. In vivo muscle oxidative capacity was not different in fa/fa animals compared to controls, and in vitro enzyme activity data suggested improved functionality of enzymes involved in fat oxidation in type 2 diabetic animals. Accordingly, we can conclude that in the ZDF rat model, type 2 diabetes develops in the absence of skeletal muscle mitochondrial dysfunction.—De Feyter, H. M., Lenaers, E., Houten, S. M., Schrauwen, P., Hesselink, M. K., Wanders, R. J. A., Nicolay, K., Prompers, J. J. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes.
Key Words: rat • NMR spectroscopy • In vivo NMR • insulin resistance • PCr recovery
This article has been cited by other articles:
|
|
 |
|
  R. C.R. Meex, V. B. Schrauwen-Hinderling, E. Moonen-Kornips, G. Schaart, M. Mensink, E. Phielix, T. van de Weijer, J.-P. Sels, P. Schrauwen, and M. K.C. Hesselink Restoration of Muscle Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes by Exercise Training Is Paralleled by Increased Myocellular Fat Storage and Improved Insulin Sensitivity Diabetes, March 1, 2010; 59(3): 572 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Taube, K. Eckardt, and J. Eckel Role of lipid-derived mediators in skeletal muscle insulin resistance Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1004 - E1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Minnaard, P. Schrauwen, G. Schaart, J. A. Jorgensen, E. Lenaers, M. Mensink, and M. K.C. Hesselink Adipocyte Differentiation-Related Protein and OXPAT in Rat and Human Skeletal Muscle: Involvement in Lipid Accumulation and Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 4077 - 4085. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
